verdinexor and Esophageal-Neoplasms

verdinexor has been researched along with Esophageal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for verdinexor and Esophageal-Neoplasms

Article	Year
Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis. International journal of biological sciences, 2022, Volume: 18, Issue:1 Topics: Acrylamides; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Esophageal Neoplasms; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Male; Mice; Mice, Nude; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Salivary alpha-Amylases; Transcription Factors	2022

Article

Year

Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis.

International journal of biological sciences, 2022, Volume: 18, Issue:1

Topics: Acrylamides; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Esophageal Neoplasms; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Male; Mice; Mice, Nude; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Salivary alpha-Amylases; Transcription Factors

2022